JANUMET

Type: Product
Name: JANUMET
First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

New report finds Bydureon safest of new class of diabetes drugs

Analysis of FDA adverse event data tries to pull together risks of three new classes of drugsShareToolsBydureon--Courtesy of AstraZenecaWith big money to be made, drugmakers have responded to the global rise in Type 2 diabetes with a host of new classes ... [Published FiercePharma - Apr 16 2014]
First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

AdverseEvents' Special Report: Examining the Comparative Safety of Type 2 Diabetes Drugs

Type 2 Diabetes Drugs Safety Review: Byetta Has Best Safety Profile, Nesina Shows Worst Safety ProfileType 2 Diabetes affects approximately 230 million people worldwide and incidence is growing at an alarming rate. To address this epidemic, new drugs ... [Published FiercePharma - Apr 16 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 1 reports

Why Big Pharma May Not Be Cashing in on Medical Marijuana

Source: Thinkstock Prohibition against marijuana seems to be soon nearing an end, partially motivated by Colorado’s tax windfall since its passage of Amendment 64 , reporting over $3.5 million in revenue for February from recreational and medical ... [Published Wall St. Cheat Sheet - Apr 08 2014]
First reported Mar 17 2014 - Updated Mar 17 2014 - 1 reports

Pharma Summit: Merck’s European president Bruno Strigini highlights importance of innovation

The president of pharma giant Merck & Co’s (NYSE: MRK) operations in Europe and Canada Bruno Strigini spoke about pharma innovation in action at The Economist’s Pharma Summit in London on Thursday.Mr Strigini said that the pharma industry is adapting ... [Published Pharma Letter - Mar 17 2014]
First reported Mar 17 2014 - Updated Mar 17 2014 - 1 reports

New plant in Tuas to produce diabetic drug

DRUG giant Merck Sharp & Dohme will officially open a facility specialising in making the diabetic medication Janumet in Tuas later this year.The plant is part of a US$250million (S$316million) agreement with the Singapore Economic Development Board made ... [Published Biotech Singapore - Mar 17 2014]
First reported Mar 15 2014 - Updated Mar 15 2014 - 1 reports

Doctors Getting Mixed News About The Diabetes Drugs

Diabetes pills referred to as DPP-4 therapies got a mixed report as according to the studies, they did not increase the heart attack risks but may be associated with heart failures. Heart failure occurs when the heart fails in pumping blood properly.Fortunately ... [Published Charles Ayoub - Mar 15 2014]
First reported Mar 12 2014 - Updated Mar 12 2014 - 1 reports

Mallinckrodt's U.S. pain drug approval brings Depomed a $10M delivery tech milestone

Mallinckrodt ($MNK) scored FDA approval for its Xartemis XR oxycodone and acetaminophen tablet, known in development as MNK-795, an opioid treatment for acute pain. The approval is also a win for Depomed ($DEPO), which owns the controlled-release technology ... [Published Fierce Drug Delivery - Mar 12 2014]
First reported Mar 12 2014 - Updated Mar 12 2014 - 1 reports

4 Reasons Why Merck is a Hold

Merck & Co. ( MRK ), the second-largest pharmaceutical company in the world by revenues, saw its revenues decline 6.8% year-over-year in fiscal 2013 (FY13) following the expiry of some of its blockbuster drug patents in 2012 and 2013. To counter the impact ... [Published Bidness Etc - Mar 12 2014]
First reported Feb 27 2014 - Updated Feb 27 2014 - 1 reports

Januvia Pancreatic Cancer Allegations Help: Resource4thePeople...

National network of lawyers continues offer of complimentary consultations to consumers seeking compensation in lawsuits alleging links between diabetes medications Januvia, Byetta, Janumet and Victoza and pancreatic cancer. http://www.resource4thepe ... [Published PRWeb - Feb 27 2014]
First reported Jan 19 2014 - Updated Jan 19 2014 - 1 reports

Januvia Pancreatic Cancer Allegations Alert: Resource4thePeople...

National network of lawyers will resume availability for inquiries from consumers seeking compensation in lawsuits alleging links between diabetes medications Januvia, Byetta, Janumet and Victoza and pancreatic cancer. http://www.resource4thepeople.c ... [Published PRWeb - Jan 19 2014]
First reported Dec 19 2013 - Updated Dec 19 2013 - 1 reports

Byetta Pancreatic Cancer Allegations Attorneys: Resource4thePeople...

National network of lawyers will continue offer of these consultations through Christmas and New Year’s Day. Allegations involve links between diabetes medications Byetta, Januvia, Janumet and Victoza and pancreatic cancers. http://www.resource4thepe ... [Published PRWeb - Dec 19 2013]
First reported Nov 05 2013 - Updated Nov 05 2013 - 3 reports

DrugNews Adds Latest Januvia Warnings And Lawsuit News

_ The diabetes drug safety center at DrugNews.net is advising patients taking the medications Januvia or Janumet of updated information on the site. The latest court records from a special federal court show a growing number of patients alleging drugs ... [Published PRWeb - Nov 05 2013]

Quotes

Dr Liew said it could "potentially benefit a lot more people here if it were more affordable"
"We are pleased the FDA has approved Xartemis XR and that our Acuform technology has contributed to this important new therapy option for patients and their physicians" Depomed CEO Jim Schoeneck said in a statement
...the plaintiffs and defendants update the judge on the progress of the litigation and any problems that have developed," said Resource4thePeople. "We will monitor these developments and continue to update consumers who are following this litigation or are considering seeking compensation in connection with these allegations." The latest figures*** provided by the U S Judicial Panel for Multidistrict Litigation shows that there are now 163 cases in the multidistrict litigation...
...29, 2013, and the defendants must file their master consolidated answer no later than Dec. 31, 2013. "This order was issued after the latest status conference on Nov. 21, 2013, at which the judge was briefed on the progress of the case by attorneys for both sides,” said Resource4thePeople. “The filing of a master complaint will define the allegations in this litigation and the response will provide an answer to the charges from the defendants."

More Content

All (57) | News (53) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
New report finds Bydureon safest of new class o... [Published FiercePharma - Apr 16 2014]
AdverseEvents' Special Report: Examining the Co... [Published FiercePharma - Apr 16 2014]
Why Big Pharma May Not Be Cashing in on Medical... [Published Wall St. Cheat Sheet - Apr 08 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Mar 27 2014]
MLV Sees A Good Chance Of FDA Approval For Mann... [Published Seeking Alpha - Mar 18 2014]
Pharma Summit: Merck’s European president Bruno... [Published Pharma Letter - Mar 17 2014]
New plant in Tuas to produce diabetic drug [Published Biotech Singapore - Mar 17 2014]
Doctors Getting Mixed News About The Diabetes D... [Published Charles Ayoub - Mar 15 2014]
Put This Specialty Pharma In Your Portfolio [Published Seeking Alpha - Mar 14 2014]
Mallinckrodt's U.S. pain drug approval brings D... [Published Fierce Drug Delivery - Mar 12 2014]
4 Reasons Why Merck is a Hold [Published Bidness Etc - Mar 12 2014]
Januvia Pancreatic Cancer Allegations Help: Res... [Published PRWeb - Feb 27 2014]
Januvia Pancreatic Cancer Allegations Alert: Re... [Published PRWeb - Jan 19 2014]
TrialNetworks Welcomes Global Pharmaceutical In... [Published PRWeb - Jan 16 2014]
Byetta Pancreatic Cancer Allegations Attorneys:... [Published PRWeb - Dec 19 2013]
Byetta Pancreatic Cancer Allegation Attorneys: ... [Published PRWeb - Nov 27 2013]
DrugRisk November Januvia Update Shows Growth i... [Published PRWeb - Nov 27 2013]
Diabetes and I [Published HealthBoards - Nov 21 2013]
DrugNews Adds Latest Court Update on Januvia La... [Published BioPortfolio - Nov 19 2013]
DrugRisk Adds Latest Court Information For Janu... [Published PRWeb - Nov 13 2013]
DrugNews Adds Byetta Resource Center With Lates... [Published PRWeb - Nov 08 2013]
DrugNews Adds Latest Januvia Warnings And Lawsu... [Published PRWeb - Nov 05 2013]
New York Attorney Now Accepting Januvia, Janume... [Published PRWeb - Nov 05 2013]
Byetta Pancreatic Cancer Allegations Lawyers: R... [Published PRWeb - Nov 05 2013]
DrugNews: Latest Court Records Show Growth of B... [Published PRWeb - Oct 26 2013]
DrugRisk Alerts of Court Update Showing Monthly... [Published PRWeb - Oct 24 2013]
DrugNews: Januvia Lawsuits Alleging Cancer Grow... [Published PRWeb - Oct 24 2013]
PDL BioPharma secures rights to diabetes royalt... [Published Pharmaceutical Technology - Oct 23 2013]
DrugRisk Announces Latest on Lawsuits Alleging ... [Published PRWeb - Oct 15 2013]
Latest Januvia Lawsuits Alleging Pancreatic Can... [Published PRWeb - Oct 14 2013]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Why Big Pharma May Not Be Cashing in on Medical... [Published Wall St. Cheat Sheet - Apr 08 2014]
Source: Thinkstock Prohibition against marijuana seems to be soon nearing an end, partially motivated by Colorado’s tax windfall since its passage of Amendment 64 , reporting over $3.5 million in revenue for February from recreational and medical ...
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Mar 27 2014]
Diabetes and I [Published HealthBoards - Nov 21 2013]
Hi,I hail from East India, aged approx. 45 years. Doc prescribed me with T2 Diabetes. Am on medication. Besides Diabetes, I am also hypertensive. Though the Blood Pressure is very much under control, I am advised by my treating Doc to continue with the ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.